Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by Benedictuson Nov 07, 2023 11:13pm
196 Views
Post# 35722848

RE:AC/DC Albums for 200 Alex

RE:AC/DC Albums for 200 Alex
TheMadMonk wrote: This 1980's Hard Rock album was the seventh studio album from the Australian music group AC/DC.  What is Back in Black?  To quote the great British rocker Brian Johnson "Well, I'm back in black, Yes, I'm back in black".  I have to admit, ATE is going up much faster than I expected.  We still have PK/PD results, Earnings Report, Corporate Update, and the verdict in the Nuance arbitration case all expected in the next four weeks or so.  I find it funny how many people were trashing this stock a few weeks ago at 46 cents and are now lining up to buy it at $1.05  Market psychology, who can figure it out?  The rest of 2023 should be very interesting.

Nice tie in there! That called for an immediate revisit to watch that music video. AC/DC...Legendary rockers! 

I was most certainly a frustrated poster, watching for 2 years what became a rather slow moving predictable chart pattern along with extremely pushed out timelines burning all that precious much needed capital. But it's most excellent to see what appears to be an ironclad timeline and momentum building toward a reformulated path to success.

My timing with this stock has been more fortuitous than many. I bought a modest position at .80c back in 2017 and then decided once the stock settled into the .45 - .55 area to 8X my initial position, so I am also enjoying being Back in Black. Here's hoping many longs are able to claim that anthem for their portfolios soon enough!!

<< Previous
Bullboard Posts
Next >>